🦁
|
Familial chilblain lupus due to a gain-of-function mutation in STING
12 auth.
N. König,
C. Fiehn,
C. Wolf,
Max Schuster,
Emanuel Cura Costa,
V. Tüngler,
...
H. A. Alvarez,
O. Chara,
K. Engel,
R. Goldbach-Mansky,
C. Günther,
M. Lee-Kirsch
|
7 |
2016 |
7 🦁
|
🐜
|
SAMHD1 prevents autoimmunity by maintaining genome stability
15 auth.
S. Kretschmer,
C. Wolf,
N. König,
W. Staroske,
J. Guck,
M. Häusler,
H. Luksch,
Laura A Nguyen,
Baek Kim,
D. Alexopoulou,
...
A. Dahl,
A. Rapp,
Cristina Cardoso,
A. Shevchenko,
Minae A Lee-Kirsch
|
7 |
2014 |
7 🐜
|
🐜
|
RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA
14 auth.
C. Wolf,
A. Rapp,
N. Berndt,
W. Staroske,
Max Schuster,
Manuela Dobrick-Mattheuer,
S. Kretschmer,
N. König,
T. Kurth,
D. Wieczorek,
...
K. Kast,
M. C. Cardoso,
C. Günther,
M. Lee-Kirsch
|
7 |
2016 |
7 🐜
|
🐜
|
Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation
7 auth.
A. Skrabl-Baumgartner,
B. Plecko,
W. Schmidt,
N. König,
M. Hershfield,
U. Gruber‐Sedlmayr,
...
M. Lee-Kirsch
|
6 |
2017 |
6 🐜
|
🐜
|
Response to: ‘JAK inhibition in STING-associated interferonopathy’ by Crow et al
9 auth.
V. Tüngler,
N. König,
C. Günther,
K. Engel,
C. Fiehn,
M. Smitka,
...
M. von der Hagen,
R. Berner,
M. Lee-Kirsch
|
4 |
2016 |
4 🐜
|
🐬
|
Typ-I-Interferonopathien
Claudia Günther,
F. Schmidt,
N. König,
M. A. Lee-Kirsch
|
3 |
2016 |
3 🐬
|
🐜
|
Effects of Janus Kinase Inhibition in Two Children with Aicardi-Goutières Syndrome
8 auth.
V. Tüngler,
N. König,
K. Engel,
M. Smitka,
K. Ungerath,
M. von der Hagen,
...
R. Berner,
M. Lee-Kirsch
|
1 |
2017 |
1 🐜
|
🦁
|
Familial chilblain lupus caused by an activating mutation in STING
N. König,
C. Fiehn,
H. Lorenz,
M. Lee-Kirsch
|
0 |
2015 |
0 🦁
|